These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 11064479

  • 41. Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.
    Barbour SJ, Beaulieu MC, Zalunardo NY, Magil AB.
    Nephrol Dial Transplant; 2011 Aug; 26(8):2712-4. PubMed ID: 21633102
    [Abstract] [Full Text] [Related]

  • 42. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Delannoy A, Hanique G, Ferrant A.
    N Engl J Med; 1993 Mar 18; 328(11):812; author reply 813. PubMed ID: 8094888
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
    Eichhorst BF, Busch R, Schweighofer C, Wendtner CM, Emmerich B, Hallek M, German CLL Study Group (GCLLSG).
    Br J Haematol; 2007 Jan 18; 136(1):63-72. PubMed ID: 17083342
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
    O'Brien S, Moore JO, Boyd TE, Larratt LM, Skotnicki A, Koziner B, Chanan-Khan AA, Seymour JF, Bociek RG, Pavletic S, Rai KR.
    J Clin Oncol; 2007 Mar 20; 25(9):1114-20. PubMed ID: 17296974
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
    Dungarwalla M, Evans SO, Riley U, Catovsky D, Dearden CE, Matutes E.
    Haematologica; 2008 Mar 20; 93(3):475-6. PubMed ID: 18310545
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
    Schierl M, Foedinger D, Geissler K, Rappersberger K, Feldmann R.
    Eur J Dermatol; 2008 Mar 20; 18(6):717-8. PubMed ID: 19049939
    [No Abstract] [Full Text] [Related]

  • 55. Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Mercadal S, Martinez A, Nomdedeu B, Rozman M, Gaya A, Salamero O, Campo E.
    Eur J Haematol; 2006 Nov 20; 77(5):442-4. PubMed ID: 17044837
    [Abstract] [Full Text] [Related]

  • 56. Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia.
    Tisler A, Pierratos A, Lipton JH.
    Nephrol Dial Transplant; 1996 Nov 20; 11(11):2306-8. PubMed ID: 8941597
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Chronic lymphocytic leukaemia: current first-line therapy.
    Carney DA, Mulligan SP.
    Intern Med J; 2009 Jan 20; 39(1):44-8. PubMed ID: 19290981
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.